2005年9月第17期
·07/05/08 Tolerance induction by bone marrow transplantation in a multiple sclerosis model
·07/05/08 effect of transcription-factor concentrations on leukemic stem cells
·07/05/08 Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells
·07/05/08 Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura
·07/05/08 Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
·07/05/08 Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy
·07/05/08 Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer
·07/05/08 Conditional overexpression of transgenes in megakaryocytes and platelets in vivo
·07/05/08 Development of functional human blood and immune systems in NOD/SCID/IL2 receptor chainnull mice
·07/05/08 A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity
·07/05/08 FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells
·07/05/08 Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation
·07/05/08 Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation
·07/05/08 Tissue-factor–bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation
·07/05/08 Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression
·07/05/08 The heparin-binding site of antithrombin is crucial for antiangiogenic activity
·07/05/08 Inhibition of APC anticoagulant activity on oxidized phospholipid by anti–2-glycoprotein I monoclonal antibodies
·07/05/08 endothelial intercellular adhesion molecule (ICAM)–2 regulates angiogenesis
·07/05/08 Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of plate
·07/05/08 Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele
·07/05/08 early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection
·07/05/08 Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation
·07/05/08 Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance
·07/05/08 Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions
·07/05/08 Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression
·07/05/08 Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand–expressing tumor cells
·07/05/08 Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn
·07/05/08 Cooperating pre–T-cell receptor and TCF-1–dependent signals ensure thymocyte survival
·07/05/08 Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys
·07/05/08 efficient migration of dendritic cells toward lymph node chemokines and induction of TH1 responses require maturation stimulus and apoptotic cell interaction
·07/05/08 Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis
·07/05/08 Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia
·07/05/08 Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
·07/05/08 AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping
·07/05/08 Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma
·07/05/08 effect of transcription-factor concentrations on leukemic stem cells
·07/05/08 Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells
·07/05/08 Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura
·07/05/08 Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
·07/05/08 Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy
·07/05/08 Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer
·07/05/08 Conditional overexpression of transgenes in megakaryocytes and platelets in vivo
·07/05/08 Development of functional human blood and immune systems in NOD/SCID/IL2 receptor chainnull mice
·07/05/08 A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity
·07/05/08 FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells
·07/05/08 Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation
·07/05/08 Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation
·07/05/08 Tissue-factor–bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation
·07/05/08 Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression
·07/05/08 The heparin-binding site of antithrombin is crucial for antiangiogenic activity
·07/05/08 Inhibition of APC anticoagulant activity on oxidized phospholipid by anti–2-glycoprotein I monoclonal antibodies
·07/05/08 endothelial intercellular adhesion molecule (ICAM)–2 regulates angiogenesis
·07/05/08 Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of plate
·07/05/08 Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele
·07/05/08 early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection
·07/05/08 Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation
·07/05/08 Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance
·07/05/08 Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions
·07/05/08 Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression
·07/05/08 Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand–expressing tumor cells
·07/05/08 Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn
·07/05/08 Cooperating pre–T-cell receptor and TCF-1–dependent signals ensure thymocyte survival
·07/05/08 Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys
·07/05/08 efficient migration of dendritic cells toward lymph node chemokines and induction of TH1 responses require maturation stimulus and apoptotic cell interaction
·07/05/08 Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis
·07/05/08 Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia
·07/05/08 Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
·07/05/08 AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping
·07/05/08 Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma
栏目列表
·2005年7月第13期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期